AnticoagEvaluator vs MAQI2 Anticoagulation Toolkit Usage & Stats

Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator. Use the app to: • Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed • Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention • Generate individualized risk for antithrombotic therapy options based on individual clinical trials. • Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics. This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com
  • Apple App Store
  • Free
  • Medical

Store Rank

- -

This mobile app provides healthcare practitioners with an up-to-date, easy-to-use resource for managing anticoagulation patients more safely and effectively. The content was developed by the Michigan Anticoagulation Quality Improvement Initiative (MAQI2), a Blue Cross Blue Shield/Blue Care Network of Michigan sponsored consortium of anticoagulation clinics and experts from across the state of Michigan, and is based on the latest guidelines and research.
  • Apple App Store
  • Free
  • Medical

Store Rank

- -

AnticoagEvaluator vs. MAQI2 Anticoagulation Toolkit ranking comparison

Compare AnticoagEvaluator ranking trend in the past 28 days vs. MAQI2 Anticoagulation Toolkit

Rank

No Data Available

AnticoagEvaluator vs. MAQI2 Anticoagulation Toolkit ranking by country comparison

Compare AnticoagEvaluator ranking trend in the past 28 days vs. MAQI2 Anticoagulation Toolkit

No Data to Display

Compare to any site with our free trial

Get started
AnticoagEvaluator VS.
MAQI2 Anticoagulation Toolkit

December 19, 2024